See more : SVB & T Corporation (SVBT) Income Statement Analysis – Financial Results
Complete financial analysis of Colgate-Palmolive Company (CL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Colgate-Palmolive Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- Brighten Optix Corporation (6747.TWO) Income Statement Analysis – Financial Results
- Merry Electronics Co., Ltd. (2439.TW) Income Statement Analysis – Financial Results
- P3 Health Partners Inc. (PIIIW) Income Statement Analysis – Financial Results
- SGT German Private Equity GmbH & Co. KGaA (SGF.DE) Income Statement Analysis – Financial Results
- Genii Ideas Co., Ltd. (7631.TWO) Income Statement Analysis – Financial Results
Colgate-Palmolive Company (CL)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.colgatepalmolive.com
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.46B | 17.97B | 17.42B | 16.47B | 15.69B | 15.54B | 15.45B | 15.20B | 16.03B | 17.28B | 17.42B | 17.09B | 16.73B | 15.56B | 15.33B | 15.33B | 13.79B | 12.24B | 11.40B | 10.58B | 9.90B | 9.29B | 9.43B | 9.36B | 9.12B | 8.97B | 9.06B | 8.75B | 8.36B | 7.59B | 7.14B | 7.01B | 6.06B | 5.69B | 5.04B | 4.73B | 5.65B | 4.98B | 4.52B |
| Cost of Revenue | 8.21B | 7.72B | 7.05B | 6.45B | 6.37B | 6.31B | 6.17B | 6.07B | 6.64B | 7.17B | 7.22B | 7.15B | 7.14B | 6.36B | 6.32B | 6.70B | 6.04B | 5.54B | 5.19B | 4.75B | 4.46B | 4.22B | 4.24B | 4.27B | 3.88B | 3.96B | 4.14B | 4.13B | 4.05B | 3.68B | 3.52B | 3.52B | 3.15B | 2.99B | 2.75B | 2.64B | 3.07B | 2.80B | 2.61B |
| Gross Profit | 11.25B | 10.25B | 10.38B | 10.02B | 9.33B | 9.23B | 9.28B | 9.12B | 9.40B | 10.11B | 10.20B | 9.93B | 9.59B | 9.20B | 9.01B | 8.63B | 7.75B | 6.70B | 6.21B | 5.84B | 5.45B | 5.07B | 5.19B | 5.09B | 5.23B | 5.01B | 4.92B | 4.61B | 4.31B | 3.91B | 3.62B | 3.49B | 2.91B | 2.70B | 2.29B | 2.09B | 2.58B | 2.18B | 1.92B |
| Gross Profit Ratio | 57.82% | 57.04% | 59.55% | 60.82% | 59.42% | 59.39% | 60.05% | 60.04% | 58.62% | 58.51% | 58.56% | 58.13% | 57.31% | 59.14% | 58.77% | 56.27% | 56.18% | 54.76% | 54.44% | 55.15% | 55.00% | 54.55% | 55.06% | 54.42% | 57.41% | 55.86% | 54.27% | 52.74% | 51.51% | 51.53% | 50.71% | 49.82% | 48.02% | 47.38% | 45.50% | 44.17% | 45.68% | 43.77% | 42.34% |
| Research & Development | 343.00M | 320.00M | 307.00M | 290.00M | 281.00M | 277.00M | 285.00M | 289.00M | 274.00M | 277.00M | 267.00M | 259.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 229.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.87B | 4.57B | 4.41B | 4.07B | 3.88B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 2.33B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Selling & Marketing | 2.37B | 2.00B | 2.00B | 1.95B | 1.69B | 1.59B | 1.57B | 1.43B | 1.49B | 1.78B | 1.89B | 1.79B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.06B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.24B | 6.57B | 6.41B | 6.02B | 5.58B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 3.40B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Other Expenses | 0.00 | 69.00M | 65.00M | 113.00M | 196.00M | -87.00M | 36.00M | 22.00M | 39.00M | 14.00M | 27.00M | 30.00M | -9.00M | 301.00M | 111.00M | 183.40M | 65.70M | 32.80M | 69.20M | 22.20M | -74.30M | 23.00M | 68.00M | 72.10M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| Operating Expenses | 7.34B | 6.63B | 6.47B | 6.13B | 5.77B | 5.54B | 5.69B | 5.27B | 5.53B | 6.55B | 6.65B | 6.04B | 5.75B | 5.41B | 5.39B | 5.61B | 5.04B | 4.39B | 3.99B | 3.65B | 3.22B | 3.06B | 3.33B | 3.37B | 3.59B | 3.53B | 3.56B | 3.37B | 3.18B | 2.86B | 2.67B | 2.69B | 2.63B | 2.14B | 1.86B | 1.73B | 2.20B | 1.85B | 1.64B |
| Cost & Expenses | 15.47B | 14.35B | 13.52B | 12.59B | 12.14B | 11.85B | 11.87B | 11.34B | 12.16B | 13.72B | 13.86B | 13.20B | 12.89B | 11.77B | 11.71B | 12.31B | 11.08B | 9.92B | 9.18B | 8.39B | 7.68B | 7.28B | 7.57B | 7.64B | 7.48B | 7.49B | 7.70B | 7.50B | 7.23B | 6.54B | 6.19B | 6.21B | 5.78B | 5.14B | 4.60B | 4.37B | 5.26B | 4.65B | 4.25B |
| Interest Income | 55.00M | 14.00M | 17.00M | 19.00M | 47.00M | 50.00M | 51.00M | 50.00M | 107.00M | 106.00M | 125.00M | 65.00M | 7.00M | 6.00M | 11.00M | 10.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 287.00M | 167.00M | 192.00M | 183.00M | 192.00M | 193.00M | 153.00M | 149.00M | 133.00M | 130.00M | 116.00M | 80.00M | 59.00M | 59.00M | 77.00M | 105.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.02B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 567.00M | 545.00M | 556.00M | 539.00M | 519.00M | 511.00M | 475.00M | 443.00M | 449.00M | 442.00M | 439.00M | 425.00M | 421.00M | 376.00M | 351.00M | 347.60M | 333.90M | 328.70M | 329.30M | 327.80M | 315.50M | 296.50M | 336.20M | 337.80M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| EBITDA | 4.25B | 4.13B | 4.37B | 4.33B | 4.16B | 4.17B | 4.12B | 4.33B | 3.35B | 4.11B | 4.12B | 4.38B | 4.27B | 3.87B | 3.98B | 3.46B | 3.06B | 2.55B | 2.61B | 2.50B | 2.47B | 2.31B | 2.17B | 2.08B | 1.98B | 1.81B | 1.68B | 1.56B | 1.43B | 1.28B | 1.16B | 991.10M | 427.80M | 680.90M | 532.40M | 445.50M | 485.30M | 421.60M | 349.00M |
| EBITDA Ratio | 21.82% | 27.16% | 28.87% | 26.86% | 25.95% | 27.05% | 26.30% | 28.66% | 33.72% | 23.15% | 22.93% | 25.25% | 25.47% | 26.77% | 25.88% | 21.97% | 22.35% | 22.54% | 22.93% | 24.14% | 24.93% | 24.52% | 23.17% | 21.46% | 22.52% | 20.24% | 18.80% | 18.93% | 23.35% | 18.02% | 17.30% | 14.44% | 6.49% | 11.92% | 8.62% | 9.55% | 11.64% | 7.64% | 6.55% |
| Operating Income | 3.98B | 4.34B | 4.47B | 3.89B | 3.55B | 3.69B | 3.59B | 3.84B | 2.79B | 3.56B | 3.56B | 3.89B | 3.84B | 3.79B | 3.62B | 3.02B | 2.65B | 2.16B | 2.22B | 2.12B | 2.17B | 2.01B | 1.86B | 1.72B | 1.64B | 1.48B | 1.36B | 1.25B | 1.13B | 1.05B | 954.30M | 798.60M | 281.60M | 554.70M | 435.40M | 363.50M | 384.00M | 332.30M | 276.80M |
| Operating Income Ratio | 20.48% | 24.13% | 25.68% | 23.59% | 22.65% | 23.76% | 23.22% | 25.25% | 17.39% | 20.59% | 20.41% | 22.76% | 22.95% | 24.35% | 23.59% | 19.70% | 19.24% | 17.65% | 19.44% | 20.05% | 21.87% | 21.66% | 19.74% | 18.39% | 17.98% | 16.54% | 15.00% | 14.24% | 13.47% | 13.83% | 13.36% | 11.40% | 4.65% | 9.75% | 8.64% | 7.68% | 6.80% | 6.67% | 6.12% |
| Total Other Income/Expenses | -592.00M | -233.00M | -245.00M | -238.00M | -253.00M | -230.00M | -220.00M | -99.00M | -26.00M | -24.00M | 9.00M | -118.00M | -52.00M | -59.00M | -77.00M | -15.70M | -89.50M | -158.70M | -80.70M | -151.20M | -124.10M | -142.80M | -166.10M | -173.30M | -245.20M | -234.10M | -255.90M | -291.20M | -762.00M | -169.50M | -118.10M | -70.70M | -63.70M | -43.30M | 11.50M | -113.20M | -261.20M | -35.30M | -1.30M |
| Income Before Tax | 3.39B | 2.66B | 3.09B | 3.65B | 3.30B | 3.46B | 3.49B | 3.74B | 2.76B | 3.53B | 3.57B | 3.87B | 3.79B | 3.43B | 3.54B | 2.93B | 2.50B | 2.00B | 2.08B | 2.00B | 2.04B | 1.87B | 1.67B | 1.57B | 1.39B | 1.25B | 1.10B | 954.60M | 363.50M | 879.90M | 836.20M | 727.90M | 217.90M | 511.40M | 446.90M | 250.30M | 122.80M | 297.00M | 275.50M |
| Income Before Tax Ratio | 17.43% | 14.80% | 17.72% | 22.14% | 21.03% | 22.29% | 22.56% | 24.60% | 17.23% | 20.45% | 20.46% | 22.67% | 22.64% | 22.04% | 23.08% | 19.08% | 18.10% | 16.36% | 18.24% | 18.92% | 20.62% | 20.12% | 17.70% | 16.75% | 15.29% | 13.93% | 12.17% | 10.91% | 4.35% | 11.60% | 11.71% | 10.39% | 3.60% | 8.99% | 8.87% | 5.29% | 2.17% | 5.96% | 6.09% |
| Income Tax Expense | 937.00M | 693.00M | 749.00M | 787.00M | 774.00M | 906.00M | 1.31B | 1.15B | 1.22B | 1.19B | 1.16B | 1.24B | 1.24B | 1.12B | 1.14B | 967.90M | 759.10M | 648.40M | 727.60M | 675.30M | 620.60M | 582.00M | 522.10M | 503.40M | 457.30M | 401.50M | 361.90M | 319.60M | 191.50M | 299.70M | 288.10M | 250.90M | 93.00M | 190.40M | 166.90M | 97.60M | 68.80M | 119.50M | 107.70M |
| Net Income | 2.30B | 1.79B | 2.17B | 2.70B | 2.37B | 2.40B | 2.02B | 2.44B | 1.38B | 2.18B | 2.24B | 2.47B | 2.43B | 2.20B | 2.29B | 1.96B | 1.74B | 1.35B | 1.35B | 1.33B | 1.42B | 1.29B | 1.15B | 1.06B | 937.30M | 848.60M | 740.40M | 635.00M | 172.00M | 580.20M | 189.90M | 477.00M | 124.90M | 321.00M | 280.00M | 192.80M | 54.00M | 177.50M | 171.90M |
| Net Income Ratio | 11.82% | 9.93% | 12.43% | 16.36% | 15.08% | 15.44% | 13.10% | 16.06% | 8.63% | 12.62% | 12.86% | 14.47% | 14.53% | 14.15% | 14.95% | 12.77% | 12.60% | 11.06% | 11.86% | 12.54% | 14.35% | 13.86% | 12.16% | 11.37% | 10.28% | 9.46% | 8.18% | 7.26% | 2.06% | 7.65% | 2.66% | 6.81% | 2.06% | 5.64% | 5.56% | 4.07% | 0.96% | 3.56% | 3.80% |
| EPS | 2.78 | 2.13 | 2.56 | 3.15 | 2.76 | 2.76 | 2.30 | 2.74 | 1.53 | 2.38 | 2.41 | 2.60 | 2.49 | 2.23 | 2.27 | 1.91 | 1.68 | 1.29 | 1.27 | 1.23 | 1.30 | 1.17 | 1.01 | 0.91 | 0.79 | 0.70 | 0.61 | 0.53 | 0.13 | 0.48 | 0.14 | 0.37 | 0.10 | 0.28 | 0.25 | 0.18 | 0.05 | 0.16 | 0.14 |
| EPS Diluted | 2.77 | 2.13 | 2.55 | 3.14 | 2.75 | 2.75 | 2.28 | 2.72 | 1.52 | 2.36 | 2.38 | 2.58 | 2.47 | 2.15 | 2.19 | 1.83 | 1.60 | 1.23 | 1.22 | 1.17 | 1.23 | 1.10 | 0.95 | 0.85 | 0.74 | 0.65 | 0.56 | 0.49 | 0.13 | 0.45 | 0.13 | 0.35 | 0.10 | 0.27 | 0.24 | 0.18 | 0.05 | 0.16 | 0.14 |
| Weighted Avg Shares Out | 827.40M | 836.40M | 845.00M | 856.80M | 859.10M | 870.60M | 881.80M | 891.80M | 902.20M | 915.10M | 930.80M | 952.20M | 976.60M | 975.60M | 999.00M | 1.01B | 1.02B | 1.03B | 1.04B | 1.06B | 1.07B | 1.09B | 1.11B | 1.15B | 1.17B | 1.18B | 1.18B | 1.17B | 1.16B | 1.17B | 1.25B | 1.25B | 1.10B | 1.06B | 1.08B | 1.07B | 1.07B | 1.11B | 929.71M |
| Weighted Avg Shares Out (Dil) | 829.20M | 838.80M | 848.30M | 859.30M | 861.10M | 873.00M | 887.80M | 898.40M | 909.70M | 924.30M | 939.90M | 960.20M | 984.00M | 1.02B | 1.05B | 1.07B | 1.07B | 1.08B | 1.09B | 1.12B | 1.13B | 1.16B | 1.19B | 1.23B | 1.25B | 1.27B | 1.27B | 1.25B | 1.16B | 1.26B | 1.29B | 1.32B | 1.10B | 1.14B | 1.12B | 1.07B | 1.07B | 1.11B | 929.71M |
The Smartest Dividend Stocks to Buy With $10,000 Right Now
These three stocks not only generate copious amounts of free cash flow, but also have the potential to continue paying higher dividends over time.
Colgate-Palmolive Webcasts 2024 Third Quarter Earnings Conference Call October 25, 2024 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2024 third quarter earnings conference call on Friday, October 25, 2024, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief...
Undervalued Dividend Kings: October 2024
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges. I rank Dividend Kings by quality score and highlight undervalued stocks for potential investment. The article provides tables and charts presenting quality scores, key...
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Colgate-Palmolive (CL) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
My Dividend Stock Portfolio: New August Dividend Record - 101 Holdings With 17 Buys
Investment activity remained high in August, focusing on BDCs aiming to increase dividend income by at least $100 each month. Main portfolio picks included Ares Capital, Hercules Capital and Goldman Sachs BDC. Adjusted dividend income hit an all-time high in...
Colgate-Palmolive (CL) Upgraded to Buy: Here's What You Should Know
Colgate-Palmolive (CL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 Soap & Cleaning Materials Stocks to Capitalize on Positive Industry Trends
Pricing strategies, innovation, digital transformation, and brand building are essential for success in the soap and cleaning materials industry amid rising costs. Companies like UL, PG, CL, HENKY, and CHD are well-positioned to succeed through these initiatives.
Source: https://incomestatements.info
Category: Stock Reports